Trademarkia Logo

Canada

C$
ZYMGREO
CANCELLED

Last Applicant/ Owned by

PHARMAZZ INC.

50 West 75th Street, Suite 105Willowbrook IL 60527

US

Serial Number

2029470 filed on 29th Jan 2020

Registration Number

TMA1117532 registered on 12th Jan 2022

Registration expiry Date

29th Jan 2030

ZYMGREO

Trademark usage description

pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, alzheimer's dise Read More

Classification Information


Class [005]
Pharmaceutical preparations, namely, medications for the treatment of ischemic stroke, hemorrhagic stroke, transient ischemic attack, Alzheimer's disease, Parkinson's disease, mixed dementia, frontotemporal dementia, dementia with Lewy bodies, vascular dementia, Wernicke-Korsakoff syndrome, Huntington's disease, Creutzfeldt Jakob disease, normal pressure hydrocephalus, spinal cord injury, traumatic brain injury, amyotrophic lateral sclerosis, multiple sclerosis, hypoxic-ischemic injury to the brain or spinal cord and neurodegenerative diseases.


Classification kind code

11

Mark Details


Serial Number

2029470

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 222
on 18th Oct 2021
Opposition Start Date Notice Sent
Submitted for opposition 26
on 23rd Sept 2021
Approved
Submitted for opposition 27
on 23rd Sept 2021
Approval Notice Sent
Submitted for opposition 22
on 17th Sept 2021
Search Recorded
Submitted for opposition 256
on 22nd Mar 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 21st May 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 20th May 2020
Created
Submitted for opposition 31
on 20th May 2020
Formalized
Submitted for opposition 228
on 29th Jan 2020
International Registration
Submitted for opposition 30
on 29th Jan 2020
Filed